Side-by-side comparison of Eli Lilly's Retatrutide (LY3437943) triple agonist and Tirzepatide (LY3298176) dual agonist: receptor targets, dose ranges, half-life, and current research data.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.